Copyright: ©Author(s) 2026.
World J Psychiatry. Oct 19, 2026; 16(10): 121314
Published online Oct 19, 2026. doi: 10.5498/wjp.121314
Published online Oct 19, 2026. doi: 10.5498/wjp.121314
Table 6 Stability of structural equation modeling structural pathways across diagnostic subgroups
| Path | ALL Std.β (95%CI) | SCZ Std.β (95%CI) | BD Std.β (95%CI) | MDD Std.β (95%CI) |
| FPG → Lipid index | -0.04 (-0.09 to 0.01) | -0.06 (-0.15 to 0.02) | -0.07 (-0.20 to 0.06) | 0.04 (-0.04 to 0.11) |
| FPG → BP index | 0.11 (0.06, 0.16) | 0.06 (-0.01 to 0.14) | 0.08 (-0.02 to 0.19) | 0.10 (0.02, 0.18) |
| FPG → Inflamm index | 0.08 (0.02, 0.15) | 0.14 (0.02, 0.26) | 0.02 (-0.08 to 0.11) | -0.01 (-0.11 to 0.07) |
| FPG → Nutrition index | -0.04 (-0.09 to 0.00) | -0.00 (-0.09 to 0.08) | -0.02 (-0.12 to 0.08) | -0.10 (-0.19 to 0.00) |
| FA → Lipid index | 0.23 (0.17, 0.27) | 0.30 (0.24, 0.38) | 0.17 (0.08, 0.26) | 0.18 (0.10, 0.26) |
| FA → BP index | 0.09 (0.05, 0.13) | 0.06 (-0.01 to 0.14) | 0.11 (0.03, 0.20) | 0.06 (-0.00 to 0.13) |
| FA → Inflamm index | -0.00 (-0.06 to 0.06) | -0.04 (-0.14 to 0.08) | -0.02 (-0.11 to 0.11) | 0.03 (-0.07 to 0.15) |
| FA → Nutrition index | -0.32 (-0.37 to -0.29) | -0.31 (-0.38 to -0.24) | -0.32 (-0.39 to -0.24) | -0.33 (-0.41 to -0.26) |
| HbA1c → Lipid index | 0.06 (0.01, 0.12) | -0.00 (-0.10 to 0.09) | 0.16 (0.03, 0.28) | 0.06 (-0.03 to 0.16) |
| HbA1c → BP index | -0.05 (-0.11 to 0.00) | -0.03 (-0.13 to 0.06) | -0.02 (-0.12 to 0.08) | -0.01 (-0.09 to 0.08) |
| HbA1c → Inflamm index | 0.04 (-0.01 to 0.10) | 0.00 (-0.10 to 0.13) | 0.11 (-0.02 to 0.24) | 0.19 (0.10, 0.29) |
| HbA1c → Nutrition index | 0.17 (0.11, 0.23) | 0.18 (0.08, 0.28) | 0.11 (0.00, 0.20) | 0.16 (0.02, 0.26) |
| Lipid → Coag (substrate) | 0.12 (0.08, 0.15) | 0.11 (0.05, 0.16) | 0.09 (0.03, 0.16) | 0.14 (0.08, 0.19) |
| BP → Coag (substrate) | 0.08 (0.05, 0.12) | 0.08 (0.03, 0.13) | 0.11 (0.03, 0.17) | 0.05 (-0.00 to 0.09) |
| Inflamm → Coag (substrate) | 0.42 (0.38, 0.46) | 0.40 (0.35, 0.45) | 0.41 (0.32, 0.51) | 0.45 (0.39, 0.50) |
| Nutrition → Coag (substrate) | -0.01 (-0.04 to 0.02) | 0.03 (-0.03 to 0.09) | -0.02 (-0.08 to 0.05) | -0.05 (-0.10 to 0.00) |
| Lipid → Coag (time) | 0.07 (0.03, 0.11) | 0.03 (-0.02 to 0.10) | 0.12 (0.03, 0.20) | 0.10 (0.05, 0.16) |
| BP → Coag (time) | 0.07 (0.04, 0.11) | 0.07 (0.03, 0.14) | 0.04 (-0.03 to 0.11) | 0.07 (0.02, 0.13) |
| Inflamm → Coag (time) | -0.02 (-0.06 to 0.01) | 0.01 (-0.03 to 0.04) | -0.07 (-0.15 to 0.00) | -0.06 (-0.14 to 0.03) |
| Nutrition → Coag (time) | -0.01 (-0.07 to 0.04) | 0.04 (-0.07 to 0.10) | -0.06 (-0.14 to 0.01) | -0.05 (-0.12 to 0.00) |
| FPG → D-dimer | 0.12 (0.04, 0.18) | 0.11 (-0.02 to 0.24) | 0.13 (-0.03 to 0.28) | 0.09 (0.00, 0.19) |
| FA → D-dimer | -0.19 (-0.27 to -0.13) | -0.24 (-0.38 to -0.12) | -0.17 (-0.33 to -0.02) | -0.16 (-0.28 to -0.06) |
| HbA1c → D-dimer | 0.03 (-0.04 to 0.11) | 0.03 (-0.10 to 0.17) | 0.06 (-0.11 to 0.21) | 0.06 (-0.05 to 0.16) |
| Lipid → D-dimer | 0.00 (-0.05 to 0.06) | 0.01 (-0.08 to 0.11) | -0.11 (-0.23 to 0.01) | 0.06 (-0.03 to 0.14) |
| BP → D-dimer | -0.03 (-0.08 to 0.02) | -0.07 (-0.14 to 0.01) | -0.04 (-0.18 to 0.10) | -0.02 (-0.11 to 0.05) |
| Inflamm → D-dimer | 0.16 (0.09, 0.26) | 0.16 (0.06, 0.29) | 0.21 (-0.02 to 0.38) | 0.11 (-0.03 to 0.35) |
| Nutrition → D-dimer | 0.08 (0.03, 0.13) | 0.06 (-0.03 to 0.15) | 0.16 (0.03, 0.27) | 0.07 (-0.01 to 0.16) |
| Coag (substrate) → D-dimer | -0.09 (-0.15 to -0.03) | -0.06 (-0.15 to 0.02) | -0.12 (-0.25 to 0.02) | -0.12 (-0.26 to -0.03) |
| Coag (time) → D-dimer | -0.02 (-0.07 to 0.03) | -0.05 (-0.15 to 0.05) | -0.05 (-0.15 to 0.06) | 0.05 (-0.02 to 0.14) |
- Citation: Wei J, Du HY, He Q, Jia SS, Luo FG, Wang YC. Glycemic indicators influence hypercoagulability via multisystem pathways in psychiatric inpatients: Structural equation modeling. World J Psychiatry 2026; 16(10): 121314
- URL: https://www.wjgnet.com/2220-3206/full/v16/i10/121314.htm
- DOI: https://dx.doi.org/10.5498/wjp.121314